FDA panel to review diet drug Acomplia in June
Diet drug Acomplia is the first in a class of drugs that operates by blocking CB-1 receptors in the brain, and has been linked to depression and other psychotic side effects. Read More...

France to reimburse only obese patients with type 2 diabetics for Acomplia
Sanofi said these conditions were published in official journal and according to it; doctors must first try other diabetic treatments available and must put the patient on a special diet program and physical workouts. Read More...

Diet Pill Acomplia will be best Seller, says DRI
DRI, the firm that did the study, said its findings were based on a survey of more than 3,000 endocrinologists with years of practice as well as on its own analysis and comparisons of the key clinical attributes of the current and emerging obesity treatments. Read More...

Acomplia Reaches Mexican Border Pharmacies
Acomplia is still to receive its approval from the U.S FDA. But now is moving further and the American population is quite satisfied by the fact that Acomplia can be purchased across the Mexican border in a few pharmacies Read More...